POS1466-HPR IMPACT OF COVID-19 PANDEMIC ON ADHERENCE BEHAVIOR OF LATIN-AMERICAN PATIENTS WITH RHEUMATIC DISEASES
Authors: I. A. Moreno-Arquieta, G. G. Sánchez Mendieta, D. E. Flores Alvarado, J. A. Esquivel Valerio, D. Á. Galarza-Delgado
Journal: Annals of the Rheumatic Diseases (2021)

Background: One of the greatest challenges of the COVID-19 pandemic for rheumatologists concerns the patient’s adherence to treatment (1). The impact of poor adherence on the effectiveness of chronic disease treatment is severe in terms of poorer health outcomes and increased health care costs (2). Information regarding covid-19 on adherence behavior in Latin-American is scarce. Objectives: The aim of this study is to describe impact of COVID-19 outbreak on adherence behavior in Latin-American population with rheumatic diseases. Methods: We carried out a descriptive, cross-sectional, self-report study through voluntary telephonic survey, to determine adherence behaviors during the COVID-19 pandemic, from September 9 th , 2020 to November 19 th , 2020, for consecutive patients of the outpatient rheumatology clinic in the Hospital Universitario (Monterrey, Nuevo Leon, Mexico), which serves a resource limited population that lack access to health insurance, from five neighboring states. A 17-items survey was designed. Baseline demographics that were collected included age, sex, rheumatologic diagnosis, current medications and patient perception of disease control. Patients were asked if they continued follow-up care, last prescribed therapy and reasons. Also, the survey assessed whether patients had any issues with medication supply and where they were obtaining information about covid-19 (could choose as many options as applicable). Transferred to SPSS for analysis for descriptive statistics. Results: A total of 150 patients were called, the survey response rate was 54.6% (n=82), with a mean completion time of 10 minutes. The mean +/- SD age of the participants was 52 +/- 15.9 years, and 95% were female. The most common self-reported diagnoses were rheumatoid arthritis (RA) (13.4%) and systemic lupus erythematosus (SLE) (13.4%) [Table 1]. Patient perception of disease control was primary good 37.8% and regular 35.4%. Patients that continued their follow-up with their rheumatologist (on the clinic face-to-face, electronically or telehealth) or in another clinic were 26.9%, the majority were nonadherent 73%. Persistence to treatment was 82.9%, the main reason to discontinue therapy was lack of prescriptions or medical advice 8.5% and overall 58.5% had trouble finding their medicine. Information regarding covid-19 was mainly obtained by television (health secretary conference) 90.2%, and the least directly from their doctor 4.8%. Table 1. Survey Results N (%) Age, mean +/- SD years 52 +/- 15.9 Female/ Male 78 (95.1) / 4 (4.9) Diagnoses RA 50(61) SLE 11(13.4) Osteoarthritis 10(12.2) Other 11(13.4) Disease Control during covid-19 Excellent 8 (9.8) Good 31 (37.8) Regular 29 (35.4) Bad 14 (17.1) Continued follow-up (face-to-face, telehealth, other) 22 (26.9) Continued last prescribed treatment 68 (82.9) Reasons to discontinue treatment Lack of prescriptions/ medical advice 7 (8.5) Lack of availability 6(7.3) Economic disadvantage 3 (3.6) Fear of getting sick of COVID-19 2(2.4) “Trouble” finding medicine 48 (58.5) COVID-19 information Television (Health Secretary conference) 74 (90.2) Social network 27 (32.9) Newspaper/ magazines 14 (17) Internet 9 (10.9) From a doctor 4 (4.8) Conclusion: Patients continue their therapeutic regimen, still many of them have trouble finding their medications, which affects the disease control. Also, despite having a poor disease control (majority between regular and bad) they are not continuing their follow-up care, more objective studies are needed to determine a specific cause. References: [1]Pineda-Sic RA, Galarza-Delgado DA, Serna-Pena G, et al. Ann Rheum Dis Epub ahead of print: [20-06-2020]. doi:10.1136/ annrheumdis-2020-218198 [2]Anghel, L. A., Farcaş, A. M., &amp; Oprean, R. N. (2018). Medication adherence and persistence in patients with autoimmune rheumatic diseases: a narrative review. Patient preference and adherence, 12, 1151–1166. https://doi.org/10.2147/PPA.S165101 Disclosure of Interests: None declared